August 9, 2024 — A recent groundbreaking clinical trial has provided the first evidence that cannabigerol (CBG), a lesser-known cannabinoid derived from hemp, could offer promising therapeutic benefits, particularly in reducing anxiety and stress. The trial, conducted by a team of researchers, represents the first human clinical study to evaluate the acute effects of CBG… Read more